BIOMAT Database Logo BIOMAT Database Logo

[Changes of the indicators of central hemodynamics in patients with hypertensive disease during treatment with obsidan]. 1974

F E Ostapiuk, and Iu N Kasatkin, and N P Gerasimova, and M B Beganova

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D006321 Heart The hollow, muscular organ that maintains the circulation of the blood. Hearts
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000319 Adrenergic beta-Antagonists Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. Adrenergic beta-Antagonist,Adrenergic beta-Receptor Blockader,Adrenergic beta-Receptor Blockaders,beta-Adrenergic Antagonist,beta-Adrenergic Blocker,beta-Adrenergic Blocking Agent,beta-Adrenergic Blocking Agents,beta-Adrenergic Receptor Blockader,beta-Adrenergic Receptor Blockaders,beta-Adrenoceptor Antagonist,beta-Blockers, Adrenergic,beta-Adrenergic Antagonists,beta-Adrenergic Blockers,beta-Adrenoceptor Antagonists,Adrenergic beta Antagonist,Adrenergic beta Antagonists,Adrenergic beta Receptor Blockader,Adrenergic beta Receptor Blockaders,Adrenergic beta-Blockers,Agent, beta-Adrenergic Blocking,Agents, beta-Adrenergic Blocking,Antagonist, beta-Adrenergic,Antagonist, beta-Adrenoceptor,Antagonists, beta-Adrenergic,Antagonists, beta-Adrenoceptor,Blockader, Adrenergic beta-Receptor,Blockader, beta-Adrenergic Receptor,Blockaders, Adrenergic beta-Receptor,Blockaders, beta-Adrenergic Receptor,Blocker, beta-Adrenergic,Blockers, beta-Adrenergic,Blocking Agent, beta-Adrenergic,Blocking Agents, beta-Adrenergic,Receptor Blockader, beta-Adrenergic,Receptor Blockaders, beta-Adrenergic,beta Adrenergic Antagonist,beta Adrenergic Antagonists,beta Adrenergic Blocker,beta Adrenergic Blockers,beta Adrenergic Blocking Agent,beta Adrenergic Blocking Agents,beta Adrenergic Receptor Blockader,beta Adrenergic Receptor Blockaders,beta Adrenoceptor Antagonist,beta Adrenoceptor Antagonists,beta Blockers, Adrenergic,beta-Antagonist, Adrenergic,beta-Antagonists, Adrenergic,beta-Receptor Blockader, Adrenergic,beta-Receptor Blockaders, Adrenergic
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

F E Ostapiuk, and Iu N Kasatkin, and N P Gerasimova, and M B Beganova
[Effect of obsidan on hemodynamics and phase indices (at rest and during physical load in patients with hypertensive disease)].
January 1977, Terapevticheskii arkhiv,
F E Ostapiuk, and Iu N Kasatkin, and N P Gerasimova, and M B Beganova
[Hemodynamics changes during treatment of hypertensive patients with reserpine and Depressin].
November 1968, Klinicheskaia meditsina,
F E Ostapiuk, and Iu N Kasatkin, and N P Gerasimova, and M B Beganova
[Hemodynamics of the lesser circulation in patients with ischemic heart disease during acute obsidan test].
June 1991, Kardiologiia,
F E Ostapiuk, and Iu N Kasatkin, and N P Gerasimova, and M B Beganova
[Various effects of obsidan on central hemodynamics].
August 1985, Klinicheskaia meditsina,
F E Ostapiuk, and Iu N Kasatkin, and N P Gerasimova, and M B Beganova
Changes in central hemodynamics during pregnancy in renal hypertensive rats.
January 1982, Clinical and experimental hypertension. Part B, Hypertension in pregnancy,
F E Ostapiuk, and Iu N Kasatkin, and N P Gerasimova, and M B Beganova
[Patient compliance of hypertensive patients in ambulatory treatment with Obsidan].
January 1986, Zeitschrift fur arztliche Fortbildung,
F E Ostapiuk, and Iu N Kasatkin, and N P Gerasimova, and M B Beganova
[Changes of the indicators of hemodynamics in patients with hypertensive disease under the effect of complex treatment and single-stage massage procedures].
January 1975, Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury,
F E Ostapiuk, and Iu N Kasatkin, and N P Gerasimova, and M B Beganova
[Regional and central hemodynamic changes during the treatment of hypertension with obsidan, apressin and their combination].
March 1981, Kardiologiia,
F E Ostapiuk, and Iu N Kasatkin, and N P Gerasimova, and M B Beganova
[Several indices of hemodynamics, gas exchange and exercise tolerance during treatment of ischemic heart disease with obsidan].
December 1976, Kardiologiia,
F E Ostapiuk, and Iu N Kasatkin, and N P Gerasimova, and M B Beganova
[Comparative evaluation of the effects of isoptin and obsidan on central and cerebral hemodynamics in patients with hypertension during physical exercise].
March 1990, Kardiologiia,
Copied contents to your clipboard!